Indo Us Bio-Tech
add_icon

Indo Us Bio-Tech

129.10
-2.55
(-1.94%)
Market Cap
₹- Cr
PE Ratio
-
Volume
37,926.00
Day High - Low
₹134.00 - ₹127.51
52W High-Low
₹388.40 - ₹109.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
- Cr
EPS
-
PB Ratio
-
Book Value
22.25
EBITDA
-
Dividend Yield
- %
Industry
FMCG
ROE Growth %
-
Debt to Equity
-
Forecast For
Actual

Company News

View All News
Caret
neutral
Indo US Bio-Tech Reports 345.21 Lakhs Net Profit in Q2 FY2026Nov 14, 2025
Indo US Bio-Tech Limited announced quarterly results with net profit of Rs 345.21 lakhs and total income of Rs 3,087.27 lakhs for the quarter ended September 30, 2025. The seed cultivation and processing company's half-year net profit reached Rs 815.45 lakhs with basic EPS of Rs 1.72 for the quarter.
neutral
Indo-US Bio-Tech Limited Shareholders Approve Re-appointment of Statutory Auditors via Postal BallotNov 14, 2025
Indo-US Bio-Tech Limited shareholders approved the re-appointment of M/s. Gautam N Associates as statutory auditors for a second term of 5 years through remote e-voting postal ballot process. The resolution received 99.9999% votes in favor from 19 members representing 12,140,249 votes, with the voting period conducted from October 15 to November 13, 2025.
neutral
Indo US Bio Tech Board Approves Re-appointment of Statutory Auditors for Second 5-Year TermOct 14, 2025
Indo US Bio Tech Ltd's Board of Directors approved the re-appointment of M/s. Gautam N Associates as Statutory Auditors for a second term of 5 years, extending until the conclusion of the 26th Annual General Meeting. The decision was made based on the Audit Committee's recommendation and requires shareholder approval through postal ballot. The Board also approved the draft Postal Ballot Notice and appointed M/s. Amrish Gandhi & Associates as Scrutinizer to conduct the postal ballot and e-voting process. The Board meeting was held on October 14, 2025, lasting 30 minutes from 10:30 a.m. to 11:00 a.m.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
11.85
-
#1 -
-
-
-
-
31.88
144.70
-
#1 -
-
-
-
-
52.16
22.30
-
#1 -
-
-
-
-
48.24
104.90
-
#1 -
-
-
-
-
37.80
129.10
-
#1 -
-
-
-
-
48.89
141.04
-
#1 -
-
-
-
-
45.55
42.00
-
#1 -
-
-
-
-
29.87
82.70
-
#1 -
-
-
-
-
36.18
31.00
-
#1 -
-
-
-
-
23.44
4.28
-
#1 -
-
-
-
-
20.19

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2020
2021
2022
TTM
Revenue
40
40
50
0
Expenses
36
35
43
0
EBITDA
4
5
7
0
Operating Profit %
10 %
13 %
14 %
0 %
Depreciation
0
0
1
0
Interest
1
1
1
0
Profit Before Tax
3
4
5
0
Tax
0
-1
0
0
Net Profit
3
5
5
0
EPS in ₹
4.18
8.07
8.27
0.00

Balance Sheet

Balance Sheet
2020
2021
2022
Total Assets
35
44
56
Fixed Assets
1
2
6
Current Assets
32
38
47
Capital Work in Progress
1
2
2
Investments
0
0
0
Other Assets
32
39
48
Total Liabilities
35
44
56
Current Liabilities
17
18
12
Non Current Liabilities
2
4
5
Total Equity
16
21
39
Reserve & Surplus
10
15
29
Share Capital
6
6
9

Cash Flow

Cash Flow
2020
2021
2022
Net Cash Flow
0
-0
-0
Investing Activities
-1
-2
-5
Operating Activities
-1
0
3
Financing Activities
2
2
3

Share Holding

% Holding
Jun 2018
Sept 2018
Apr 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
70.54 %
70.54 %
70.54 %
70.54 %
70.54 %
70.54 %
70.54 %
72.19 %
73.01 %
73.01 %
73.01 %
73.01 %
73.01 %
73.01 %
73.01 %
74.02 %
70.17 %
70.17 %
70.17 %
70.17 %
70.17 %
70.17 %
70.17 %
70.17 %
70.17 %
70.17 %
70.17 %
70.17 %
70.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
24.62 %
26.90 %
28.60 %
26.28 %
27.34 %
23.92 %
24.25 %
24.00 %
22.62 %
21.55 %
22.23 %
22.39 %
23.28 %
23.15 %
23.05 %
22.73 %
24.65 %
24.52 %
24.46 %
24.52 %
24.40 %
24.43 %
24.42 %
23.98 %
23.80 %
24.21 %
24.34 %
24.36 %
24.14 %
Others
4.84 %
2.56 %
0.86 %
3.18 %
2.12 %
5.54 %
5.21 %
3.81 %
4.37 %
5.44 %
4.76 %
4.60 %
3.71 %
3.83 %
3.93 %
3.26 %
5.18 %
5.32 %
5.38 %
5.31 %
5.44 %
5.40 %
5.40 %
5.85 %
6.03 %
5.61 %
5.49 %
5.47 %
5.69 %
No of Share Holders
194
173
170
187
191
191
188
177
175
189
201
214
267
254
255
233
259
235
251
318
1,227
1,183
1,133
838
780
2,828
2,780
3,112
4,130

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Jan 2018 CHANGE OF NAME Change Of Name
NA
11 Jan 2018 0.00 0.00
29 Oct 2021 DIVIDEND Dividend
₹ 0.25 /share
28 Oct 2021 80.58 74.17
BONUS Bonus
1:5
29 Nov 2021 74.17 0.00
29 Aug 2023 BONUS Bonus
1:1
29 Aug 2023 394.90 544.80
30 Sept 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2023 235.90 244.40
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 330.00 293.10
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 250.00 232.00
03 Dec 2024 DIVIDEND Dividend
₹ 0.25 /share
03 Dec 2024 251.65 308.80
11 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2025 229.49 226.02
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2025 148.68 148.10
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 169.40 164.05
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 148.50 135.60
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 135.52 130.38

Announcements

Indo US Biotech Limited Is Proud To Announce Its Participation In The APSA Seed Congress 2025 Taking Place In Mumbai From 17Th To 20Th November 2025.Nov 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Results-Financial Results For September 30 2025 Nov 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday November 14 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Nov 14, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 14, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) 2015 In Relation To The Postal Ballot.Nov 14, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th November 2025Nov 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 15, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 14Th October 2025 Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015Oct 14, 2025
Board Meeting Intimation for Intimation Of Board Meeting On Shorter Notice Under Regulation 29 Of SEBI (LODR) Regulations 2015Oct 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -Proceedings Of 21St Annual General Meeting Of The Company Held On Tuesday September 30 2025.Sep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Reg. 34 (1) Annual Report.Aug 28, 2025
Annual ReportAug 28, 2025
Intimation Of Book Closure For The Purpose Of 21St AGM Pursuant To Regulation 42 Of SEBI (LODR) Aug 28, 2025
Shareholder Meeting-AGM On September 30 2025Aug 28, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 28Th August 2025.Aug 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Financial Results For June 30 2025Aug 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On August 12 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. Aug 12, 2025
Board Meeting Intimation for Considering And Approving Unaudited Financial Results For The Quarter Ended On 30-06-2025Aug 04, 2025
Announcement Under Regulation 30 (LODR)- Clarification On Price MovementJul 23, 2025
Clarification sought from Indo Us Bio-Tech LtdJul 22, 2025
Memorandum Of Understanding (MOU) Between Our Company INDO US BIO TECH LIMITED And ICAR-IARI For The Maize Hybrid HQPM-5 Variety.Jul 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Closure of Trading WindowJun 26, 2025
Initial Disclosure Requirements For Non Applicability Of Large EntitiesJun 26, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2025
Integrated Filing (Financial)May 26, 2025
Board Meeting Outcome for Outcome Of Board MeetingMay 26, 2025
Board Meeting Intimation for Consider And Approve Audited Financial Results For The Quarter And Year Ended On 31-03-2025.May 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Closure of Trading WindowMar 26, 2025
Promoter Of The Company Is Going To Abroad For Business Development PurposeMar 17, 2025
Promoter Cum Executive Director And One Promoter Of The Company Is Going To Abroad For Business Development Purpose.Mar 11, 2025
Promoter Cum Managing Director Promoter Cum Executive Director And One Promoter Of The Company Is Going To Abroad For Business Development Purpose.Feb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2025
Integrated Filing (Financial)Feb 11, 2025
Results-Financial Results For December 31 2024Feb 11, 2025
Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended On 31-12-2024Feb 11, 2025
Board Meeting Intimation for Consider Approve And Take On Record The Un-Audited Financial Results Of The Company Along With The Limited Review Reports For The Quarter And Nine Months Ended December 31Feb 03, 2025
Integrated Filing (Governance)Jan 16, 2025

Technical Indicators